MedPath

Effect of Atomoxetin Versus Ritalin in pediatric outpatients

Phase 2
Conditions
attention deficit-hyperactivity disorder.
Attention-deficit hyperactivity disorder, unspecified type
Registration Number
IRCT20170606034348N1
Lead Sponsor
Babol University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

ADHD disorder (all types) was diagnosed on the base of attention deficit-hyperactivity DSM-V system criteria.
patients with ADHD diagnosis who were maltreated
cardiac, renal or chronic diseases which have required special care.
patients haven’t used MAOI drugs during recent 15 days

Exclusion Criteria

eating disorders; substance use disorders; psychiatric disorders such as tic, mental, pervasive developmental disorders,personal or familial history of Turette syndrome; seizure; history of Hyperthyroidism, glaucoma; using of drugs that are contraindicated with Ritalin or tomoxetin; patients with history of no response to prior medications of ADHD; occurrence of menstruation in girls.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ADHD-RS questionnaire. Timepoint: at the end of 4th and 8th weeks after starting treatment. Method of measurement: ADHD-RS questionnaire or attention deficit hyper activity disorder rating scale is a questionnaire which has 18 questions used for a measurement of ADHD recovery in different studies.Time for filling out the questionnaire is about 5 minutes.Psychologist asks questions from children and then completes the form of questionnaire and rates the answers.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath